Plain-English translation of NCT06093022 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This is a long-term observational study comparing two approaches for patients with breast cancer that has spread to the liver: surgical removal of the affected liver tissue versus medical treatment (such as chemotherapy or other drugs) alone. Researchers at 9 medical centers worldwide will review medical records from patients treated over the past 30 years and follow new patients going forward to see which approach helps people live longer and stay cancer-free.
When breast cancer spreads to the liver, doctors are not always certain whether surgically removing the affected liver tissue in addition to medication gives patients better outcomes than medication alone. This study aims to answer that question by examining real-world outcomes across many patients and treatment centers.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to access your medical records and follow your health outcomes over five years. For patients enrolled prospectively (going forward), this may include periodic check-ins and monitoring of your cancer status, recurrence rates, and overall health. No additional hospital visits or procedures beyond your normal cancer care are required—the study simply tracks information already being collected as part of your treatment.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Italy
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment target
~720 participants
Started
April 2018
Primary completion
October 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amelia Mattia, MD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.